| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b8be6a6c990669567cc455d32b00535e |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-55 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-0202
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-435 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-435
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04 |
| filingDate |
1996-06-10^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2001-07-11^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_00f49d8e3e6363c1d1809858a7a5cb0d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_60e303c1a7bcf85f123f6923cc569411
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6dfd07e1663eba0b4ce8bdbe821775c9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0350097d37950505655697aed25cc72c |
| publicationDate |
2001-07-11^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
TW-445146-B |
| titleOfInvention |
Imidazo [1,5a] pyridine derived serine protease inhibitors |
| abstract |
The invention relates to an imidazo [1,5a] pyridine derived serine protease inhibitor comprising a unit having the general formula I wherein R1 is hydrogen, lower alkyl or an acyl group; R2 is hydrogen or lower alkyl; R3 and R4 are independently hydrogen, lower alkyl or together form =CH-NR5R6, R5 and R6 being lower alkyl. The compounds are serine protease inhibitors and can be used for the treatment and prophylaxis of thrombosis and thrombin-associated diseases. |
| priorityDate |
1995-06-02^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |